Scientific Advances in Lung Cancer 2015

Cited by (285)

Items 101–200 of 285

1. Photo-responsive magnetic mesoporous silica nanocomposites for magnetic targeted cancer therapy
   Yitong Wang, Ling Wang, Luxuan Guo, Maiomiao Yan, Lei Feng, Shuli Dong, Jingcheng Hao · 2019 · New Journal of Chemistry
2. Liquid biopsy in non-small cell lung cancer: a meta-analysis of state-of-the-art and future perspectives
   Sara Franzi, Gabriele Seresini, Paola Borella, Paola Rafaniello Raviele, Gianluca Bonitta, Giorgio Alberto Croci, Claudia Bareggi, Davide Tosi, Mario Nosotti, Silvia Maria Tabano · 2023 · Frontiers in Genetics
3. Evaluation of Merkel cell polyomavirus in non-small cell lung cancer and adjacent normal cells
   Anahita Behdarvand, Mohammad Saber Zamani, Farzin Sadeghi, Yousef Yahyapour, Farzam Vaziri, Fatemeh Rahimi Jamnani, Bahareh Nowruzi, Abolfazl Fateh, Seyed Davar Siadat · 2017 · Microbial Pathogenesis
4. Establishment of highly metastatic KRAS mutant lung cancer cell sublines in long-term three-dimensional low attachment cultures
   Tomoyuki Nakano, Yoshihiko Kanai, Yusuke Amano, Taichiro Yoshimoto, Daisuke Matsubara, Tomoki Shibano, Tomoko Tamura, Sachiko Oguni, Shizuka Katashiba, Takeshi Ito et al. · 2017 · PLoS ONE
5. Liquid biopsy in non-small cell lung cancer: a key role in the future of personalized medicine?
   Can Pi, Mingfeng Zhang, Xiaoxiao Peng, Yichen Zhang, Chong‐Rui Xu, Qing Hua Zhou · 2017 · Expert Review of Molecular Diagnostics
6. Optimizing Patient Outcomes with PD‐1/PD‐L1 Immune Checkpoint Inhibitors for the First‐Line Treatment of Advanced Non–Small Cell Lung Cancer
   Ninh My La-Beck, D.T. Nguyen, Alexander D Le, Saeed K Alzghari, Saralinh Trinh · 2020 · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
7. Spatiotemporal dissection of tumor microenvironment via in situ sensing and monitoring in tumor-on-a-chip
   Lang Zhou, Lunan Liu, Muammar Ali Chang, Chao Ma, Weiqiang Chen, Pengyu Chen · 2023 · Biosensors and Bioelectronics
8. Circular RNA hsa_circ_0050386 suppresses non-small cell lung cancer progression via regulating the SRSF3/FN1 axis
   Jinbin Chen, Boqi Rao, Zeqin Huang, Chen Xie, Yonghui Yu, Binyao Yang, Di Wu, Dedong Wang, Fuman Qiu, Yifeng Zhou et al. · 2024 · Journal of Translational Medicine
9. The role of endobronchial ultrasound transbronchial needle aspiration for programmed death ligand 1 testing and next generation sequencing in advanced non-small cell lung cancer
   Udit Chaddha, D. Kyle Hogarth, Septimiu Dan Murgu · 2019 · Annals of Translational Medicine
10. Clinical analysis of 23 patients pathologically diagnosed with primary and secondary pulmonary enteric adenocarcinoma
    Lei Gu, Xuzhou Wang, Wen Wen, Jing Lin, Xi-Fang Chen, Guoxiang Lai, Lu Chen, Xiaojuan Ouyang, Lei Zhang, Jia Ye et al. · 2019 · Chinese Medical Journal
11. Cetuximab combined with natural killer cells therapy: an alternative to chemoradiotherapy for patients with advanced non-small cell lung cancer (NSCLC).
    Shuzhen Liang, Mao Lin, Lizhi Niu, Kecheng Xu, Xiaohua Wang, Yingqing Liang, Mingjie Zhang, Duanming Du, Jibing Chen · 2018 · Europe PMC (PubMed Central)
12. Prognostic significance of anaplastic lymphoma kinase rearrangement in patients with completely resected lung adenocarcinoma
    Yinglei Liu, Xiangyun Ye, Yongfeng Yu, Shun Lü · 2019 · Journal of Thoracic Disease
13. Consensus Statement on a Screening Programme for the Detection of Early Lung Cancer in Poland
    Witold Rzyman, Joanna Aleksandra Didkowska, Robert Dziedzic, Tomasz Grodzki, Tadeusz Maria Orlowski, Edyta Szurowska, Renata Langfort, Wojciech Biernat, Dariusz Mirosław Kowalski, Wojciech Dyszkiewicz et al. · 2018 · Advances in respiratory medicine
14. Disease burden of trachea, bronchus and lung cancer 1990–2021 and global trends projected to 2035
    Xin Zhang, Jing Zou, Jinghua Ning, Run Qu, Yanhong Zhao, Congcong Lv, Yi Liang, Yuzhe Zhang · 2025 · Scientific Reports
15. Transformation of NSCLC to SCLC harboring EML4–ALK fusion with V1180L mutation after alectinib resistance and response to lorlatinib: A case report and literature review
    Lingling Xu, Chen Maoxi, Wei Ye, Zhao Jieting, Yao Yuanyuan, Ning Xu · 2023 · Lung Cancer
16. A large, single‐center, real‐world study of clinicopathological characteristics and treatment in advanced ALK ‐positive non‐small‐cell lung cancer
    Gang Chen, Xi Chen, Yaxiong Zhang, Fang Yan, Wenfeng Fang, Yunpeng Yang, Shaodong Hong, Siyu Miao, Manli Wu, Xiaodan Huang et al. · 2017 · Cancer Medicine
17. Risk Factors Associated with a Second Primary Lung Cancer in Patients with an Initial Primary Lung Cancer
    Amanda Fisher, Seongho Kim, Dina Farhat, Kimberly Belzer, MaryAnn Milczuk, Courtney French, Hirva Mansurali Mamdani, Ammar W. Sukari, Frank Alexander Baciewicz, Ann G. Schwartz et al. · 2021 · Clinical Lung Cancer
18. Antibody Drug Conjugates in Lung Cancer: State of the Current Therapeutic Landscape and Future Developments
    Joshua E. Reuss, Laura Gosa, Stephen V. Liu · 2021 · Clinical Lung Cancer
19. Computer-Assisted Image Processing System for Early Assessment of Lung Nodule Malignancy
    Ahmed Shaffie, Ahmed Soliman, Amr Eledkawy, Victor H. van Berkel, Ayman S El-Baz · 2022 · Cancers
20. Genome‐wide CRISPR/Cas9 screening for therapeutic targets in NSCLC carrying wild‐type TP53 and receptor tyrosine kinase genes
    Qianqian Wang, Jun Li, Jing Zhu, Jiaqi Mao, Chao Duan, Xiao Liang, Lingyun Zhu, Mengyan Zhu, Zhihong Zhang, Fan Lin et al. · 2022 · Clinical and Translational Medicine
21. Evaluating the effectiveness of RNA in‐situ hybridization for detecting lung adenocarcinoma with anaplastic lymphoma kinase rearrangement
    Naoki Nakajima, Akihiko Yoshizawa, Kyoko Kondo, Mariyo Rokutan‐Kurata, Masahiro Hirata, Ayako Furuhata, Shinji Sumiyoshi, Makoto Sonobe, Toshi Menju, Masanobu Momose et al. · 2017 · Histopathology
22. Automated pulmonary nodule detection system in computed tomography images based on Active-contour and SVM classification algorithm
    Faridoddin Shariaty, V V Davydov, V V Yushkova, Alexey P. Glinushkin, V. Yu. Rud’ · 2019 · Journal of Physics Conference Series
23. Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity
    Daan A. van den Broek, T. Jeroen N. Hiltermann, Bonne Biesma, Winand N.M. Dinjens, Nils A. ‘t Hart, John W. J. Hinrichs, Mathie P.G. Leers, Kim Monkhorst, Matthijs F.M. van Oosterhout, Volkher Scharnhorst et al. · 2020 · Frontiers in Oncology
24. Tumor-Derived Exosomal eIF4E as a Biomarker for Survival Prediction in Patients with Non-Small Cell Lung Cancer
    Dong Qian, Liangliang Dong, Sheng Liu, Yan Kong, Mi Zhang, Xingwen Wang · 2020 · Medical Science Monitor
25. Silencing of lncRNA AFAP1-AS1 suppressed lung cancer development by regulatory mechanism in cis and trans
    Baoying Peng, Anfei Liu, Xuanwei Yu, Enwu Xu, Jiabin Dai, Mengcheng Li, Qiaoyuan Yang · 2017 · Oncotarget
26. A Comparative Study of Genetic Profiles of Key Oncogenesis-Related Genes between Primary Lesions and Matched Lymph Nodes Metastasis in Lung Cancer
    Yuqiao Chen, Beibei Mao, Xiong Peng, Yuan Zhou, Kun Xia, Hao Guo, Hong Feng Jiang, Guo Wang, Wei Zhuang · 2019 · Journal of Cancer
27. mTORC1 inhibitor RAD001 (everolimus) enhances non-small cell lung cancer cell radiosensitivity in vitro via suppressing epithelial–mesenchymal transition
    Yu Chen, Wenwen Li, Ping Peng, Weiheng Zhao, Yijun Tian, Yu Huang, Shu Xia, Yuan Chen · 2019 · Acta Pharmacologica Sinica
28. Enkurin domain containing 1 (ENKD1) regulates the proliferation, migration and invasion of non‐small cell lung cancer cells
    Ting Song, Peng Zhou, Chunjiao Sun, Na He, Haixia Li, Jie Ran, Jun Zhou, Yue Wu, Min Liu · 2021 · Asia-Pacific Journal of Clinical Oncology
29. Brain Metastases Management in Oncogene-Addicted Non-Small Cell Lung Cancer in the Targeted Therapies Era
    Elisa De Carlo, Elisa Bertoli, Alessandro Del Conte, Brigida Stanzione, Eleonora Berto, Alberto Revelant, Michele Spina, Alessandra Bearz · 2022 · International Journal of Molecular Sciences
30. Oncogene Addicted Non-Small-Cell Lung Cancer: Current Standard and Hot Topics
    Silvia Vecchiarelli, Chiara Bennati · 2018 · Future Oncology
31. Targeted sequencing analysis of cell-free DNA from metastatic non-small-cell lung cancer patients: clinical and biological implications
    Raffaella Pasquale, Laura Forgione, Cristin Roma, Francesca Fenizia, Francesca Bergantino, Anna Maria Rachiglio, Antonella De Luca, Marianna Gallo, Monica Rosaria Maiello, Giuliano Palumbo et al. · 2020 · Translational Lung Cancer Research
32. Advances in Oligonucleotide Aptamers for NSCLC Targeting
    Deborah Rotoli, Laura Santana-Viera, Maria Luigia Ibba, Carla Lucia Esposito, Silvia Catuogno · 2020 · International Journal of Molecular Sciences
33. Lorlatinib – Induced pulmonary arterial hypertension
    Alexandre Chabrol, Marie Mayenga, Abdul Momen Hamid, Sylvie Friard, Hélène Salvator, Hélèe Doubre, Severine Moreau Fraboulet, Anne-Cécile Métivier, Émilie Catherinot, Elisabeth RIVAUD et al. · 2018 · Lung Cancer
34. The Two Sides of Dietary Antioxidants in Cancer Therapy
    Musbau Adewumi Akanji, Heritage Demilade Fatinukun, Damilare Emmanuel Rotimi, Boluwatife Lawrence Afolabi, Oluyomi Stephen Adeyemı · 2020 · IntechOpen eBooks
35. Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer
    Dennis Ruder, Vassiliki A. Papadimitrakopoulou, Kazuhiko Shien, Carmen Behrens, Neda Kalhor, Huiqin Chen, Li Shen, J. Jack Lee, Waun Ki Hong, Ximing Tang et al. · 2018 · Oncotarget
36. Expression of C-terminal ALK, RET, or ROS1 in lung cancer cells with or without fusion
    Koh Furugaki, Marie Mochizuki, Mirei Kohno, Sei Shu, Naoki Harada, Yasushi Yoshimura · 2019 · BMC Cancer
37. Establishment and validation of an immune-associated signature in lung adenocarcinoma
    Zhenyu Wang, Xiaoman Chen · 2020 · International Immunopharmacology
38. The expression levels of CYP3A4 and CYP3A5 serve as potential prognostic biomarkers in lung adenocarcinoma
    Qixing Mao, Juqing Xu, Wang Yajing, Gaochao Dong, Xia Wenjie, Shi Run, Anpeng Wang, Lin Xu, Feng Jiang, Wang Jun · 2017 · Tumor Biology
39. Synthesis and biological evaluation of novel 1,2,3-triazole hybrids of cabotegravir: identification of potent antitumor activity against lung cancer
    Yajie Guo, Dan Sang, Bin Guo, Dan Wang, Xinyue Xu, Huili Wang, Cuilan Hou, Longfei Mao, Fang Li, Sanqiang Li · 2023 · Frontiers in Pharmacology
40. Advances in the use of surgery and multimodality treatment for N2 non-small cell lung cancer
    Paul E. Van Schil, Suresh Krishan Yogeswaran, Jeroen M. Hendriks, Patrick Lauwers, Corinne Faivre Finn · 2017 · Expert Review of Anticancer Therapy
41. Andrographolide Against Lung Cancer-New Pharmacological Insights Based on High-Throughput Metabolomics Analysis Combined with Network Pharmacology
    Wen Luo, Jia Li, Jiawen Zhang, Dongjie Wang, Qiu Ren, Wei Zhang · 2021 · Frontiers in Pharmacology
42. Overcoming the Implementation Gap in Multidisciplinary Oncology Care Programs
    Raymond Uyiosa Osarogiagbon · 2016 · Journal of Oncology Practice
43. The impact of exogenous CO releasing molecule CORM‑2 on inflammation and signaling of orthotopic lung cancer
    Li Wei Shao, Congyang Liu, Shuhua Wang, Jiannan Liu, Li Wang, Liping Lv, Yong Zou · 2018 · Oncology Letters
44. Qualitative study of patients’ decision-making when accepting second-line treatment after failure of first-line chemotherapy
    Jean-Louis Pujol, Benoît Roch, Caroline Roth, Jean-Pierre Mérel · 2018 · PLoS ONE
45. Serum magnesium levels and lung cancer risk: a meta-analysis
    Xinghui Song, Xiaoning Zhong, Kaijiang Tang, Gang Wu, Yin Jiang · 2018 · World Journal of Surgical Oncology
46. Pathologic complete response to preoperative immunotherapy in a lung adenocarcinoma patient with bone metastasis: A case report
    Yong Tang, Yadan Li, Lei Zhang, Guihui Tong, Zhu’an Ou, Zhuocai Wang, Henghui Zhang, Guibin Qiao · 2020 · Thoracic Cancer
47. Down-regulated GATA-1 up-regulates interferon regulatory factor 3 in lung adenocarcinoma
    Lulu Wang, Zhengsen Chen, Wendi Zhou, Jin Shu, Xiaohua Wang, Rui Jin, Lili Zhuang, Mir Alireza Hoda, Hao Zhang, Guoping Zhou · 2017 · Scientific Reports
48. To quantify the small-molecule kinase inhibitors ceritinib, dacomitinib, lorlatinib, and nintedanib in human plasma by liquid chromatography/triple-quadrupole mass spectrometry
    G. Veerman, Peter de Bruijn, Anne‐Marie C. Dingemans, Ron H.J. Mathijssen, Stijn L.W. Koolen · 2020 · Journal of Pharmaceutical and Biomedical Analysis
49. Abnormal Expression and Prognostic Significance of Bone Morphogenetic Proteins and Their Receptors in Lung Adenocarcinoma
    Zhixiao Xu, Chengshui Chen · 2021 · BioMed Research International
50. Oligometastatic Disease in Non-Small-Cell Lung Cancer: An Update
    Yi-Hsing Chen, Ue‐Cheung Ho, Lu‐Ting Kuo · 2022 · Cancers
51. Challenges of Conducting Value Assessment for Comprehensive Genomic Profiling
    Jean‐Éric Tarride, Toby Gould, David Morgan Thomas · 2022 · International Journal of Technology Assessment in Health Care
52. Rosthorin A inhibits non-small cell lung cancer cell growth and metastasis through repressing epithelial-mesenchymal transition via downregulating Slug
    Lulu Ni, Zhongjie Li, Xuelin Shi, Chao Yao, Jiangnan Sun, Min Ai, Shuangshuang Li, Yixiao Liu, Fei Xu, Yuetao Zhou et al. · 2020 · Anti-Cancer Drugs
53. The oncogenic potential of a mutant TP53 gene explored in two spontaneous lung cancer mice models
    Julian Ramelow, Christopher D. Brooks, Li Gao, Abeer Almiman, Terence Marques Williams, Miguel Angel Villalona-Calero, Wenrui Duan · 2020 · BMC Cancer
54. Out‐of‐the‐Box Nanocapsules Packed with On‐Demand Hydrophobic Anticancer Drugs for Lung Targeting, Esterase Triggering, and Synergy Therapy
    Di Shun Zhao, Kai Jiang, Yuqi Wang, Jin Quan Cheng, Fangli Mo, Tao Luo, Yuanyuan Guo, Chuan Zhang, Jie Song · 2021 · Advanced Healthcare Materials
55. Correlation of m6A methylation with immune infiltrates and poor prognosis in non-small cell lung cancer via a comprehensive analysis of RNA expression profiles
    Bo Dong, Chunli Wu, Shi-Hao Li, Lan Huang, Chunyang Zhang, Bin Wu, Yinliang Sheng, Yafei Liu, Guanchao Ye, Yu Qi · 2021 · Annals of Translational Medicine
56. Portuguese Consensus Recommendations for Next-Generation Sequencing of Lung Cancer, Rare Tumors, and Cancers of Unknown Primary Origin in Clinical Practice
    Manuel Rodrigues Teixeira, Júlio Oliveira, Paula Borralho, Maria Gabriela O. Fernandes, Teresa Almodôvar, Isabel Fernandes, Daniela Macedo, Ana Eliza Francisco Ferreira, Ana Barroso, Encarnação Teixeira et al. · 2022 · Acta Médica Portuguesa
57. Glycemic index, glycemic load, and lung cancer risk: A meta-analysis of cohort and case-control studies
    Hong‐Zhen Du, Tianfeng Zhang, Xuning Lu, Meicui Chen, Xiaoling Li, Zengning Li · 2022 · PLoS ONE
58. Detection and comparison of EGFR mutations from supernatants that contain cell‐free DNA and cell pellets from FNA non–small cell lung cancer specimens
    Wei Wu, Yan Huang, Junhong Guo, Xiaofeng Xie, Hui Li, Ziyang Cao, Haiting Wei, Chunyan Wu · 2020 · Cancer Cytopathology
59. Bone Metastases in Lung Cancer
    Ana Cecilia Belzarena · 2021 · IntechOpen eBooks
60. Targeting MET Exon 14 Skipping Alterations: Has Lung Cancer MET Its Match?
    Timothy Anthony Yap, Sanjay Popat · 2016 · Journal of Thoracic Oncology
61. Association between Polymorphism of Genes IL-1A, NFKB1, PAR1, TP53, and UCP2 and Susceptibility to Non-Small Cell Lung Cancer in the Brazilian Amazon
    Esdras Edgar Batista Pereira, Antônio André Conde Modesto, Bruno Melo Fernandes, Rommel Mário Rodríguez Burbano, Paulo Pimentel de Assumpção, Marianne Rodrigues Fernandes, João Farias Guerreiro, Sidney Emanuel Batista dos Santos, Ney Pereira Carneiro dos Santos · 2023 · Genes
62. Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer
    Giulia Maria Stella, Sara Lettieri, Davide Piloni, Ilaria Ferrarotti, Fabio Perrotta, Angelo Guido Corsico, Chandra Bortolotto · 2023 · Pharmaceuticals
63. METTL3 / IGF2BP1 influences the development of non‐small‐cell lung cancer by mediating m6A methylation modification of TRPV1
    Wenjie Bai, Gang Xiao, Guijing Xie, Zhibo Chen, Xie Xu, Jie Zeng, Jianjiang Xie · 2024 · Thoracic Cancer
64. Helical-Tip Needle for Transthoracic Percutaneous Image-Guided Biopsy of Lung Tumors: Results of a Pilot Prospective Comparative Study with a Standard Tru-Cut Needle
    Andrea Veltri, Marco Busso, Diego Sardo, Valeria Angelino, Adriano Massimiliano Priola, Silvia Novello, Matteo Barba, Gaia Gatti, Luisella Righi · 2017 · CardioVascular and Interventional Radiology
65. [Pharmacology and Clinical Evaluation of Ensartinib Hydrochloride Capsule].
    Yang Wang, Xiaobin Yuan, Jiayan Xiong, Zhidong Hao, Xingzhe Peng, Wanlin Chen, Lingling Cui, Hua Li, Xiulan Wang, Xiangbo He et al. · 2020 · PubMed Central
66. Feasibility of Randomized Controlled Trials for Cancer Drugs Approved by the Food and Drug Administration Based on Single-Arm Studies
    Rebekah Rittberg, Piotr Marek Czaykowski, Saroj Niraula · 2021 · JNCI Cancer Spectrum
67. Concordance Between Tissue ALK Detection by Immunohistochemistry and Plasma ALK Detection by Next-Generation Sequencing in the Randomized Phase 3 ALEX Study in Patients With Treatment-Naive Advanced ALK-Positive NSCLC
    Johannes Noé, Walter Bordogna, Venice Rosalie Archer, Vlatka Smoljanović, Magalie Hilton, Ryan Woodhouse, Simonetta Mocci, Shirish M. Gadgeel · 2022 · JTO Clinical and Research Reports
68. From targeted therapy to a novel way: Immunogenic cell death in lung cancer
    Jiawei Xu, Yiyi Xiong, Zhou Xu, Hongquan Xing, Lingyun Zhou, Xinyi Zhang · 2022 · Frontiers in Medicine
69. Plasmodium Circumsporozoite Protein Enhances the Efficacy of Gefitinib in Lung Adenocarcinoma Cells by Inhibiting Autophagy via Proteasomal Degradation of LC3B
    Xiao Lu, Jiao Zhang, Yanqi Li, Quanxing Liu, Dong Zhou, Xu‐Feng Deng, Yuan Qiu, Qian Chen, Manyuan Li, Xiao-Qing Liu et al. · 2022 · Frontiers in Cell and Developmental Biology
70. Effects of preoperative pulmonary function on perioperative outcomes after robotic-assisted pulmonary lobectomy
    Collin B. Chase, Rahul Suresh Mhaskar, Cole R. Fiedler, William J. West, Ajay K. Varadhan, Jessica Cobb, Sarah Cool, Gregory Fishberger, Maykel Dolorit, Emily E. Weeden et al. · 2023 · The American Journal of Surgery
71. The cytotoxic activity of carfilzomib together with nelfinavir is superior to the bortezomib/nelfinavir combination in non-small cell lung carcinoma
    Lenka Bešše, Marianne Kraus, Andrej Bešše, Christoph Driessen, Ignazio Tarantino · 2023 · Scientific Reports
72. Oral targeted therapy for the treatment of non–small cell lung carcinoma
    William James Phillips, Natasha B. Leighl, Normand Blais, Paul Wheatley‐Price · 2024 · Canadian Medical Association Journal
73. In vivo study of tetraprenyltoluquinone, an anticancer compounds from Garcinia cowa Roxb
    Fatma Sri Wahyuni, Lim Siang Hui, Johnson Stanslas, Nordin H. Lajis, Dachriyanus Dachriyanus · 2017 · Journal of Young Pharmacists
74. Novel method for rapid fluorescence in-situ hybridization of ALK rearrangement using non-contact alternating current electric field mixing
    Satoshi Fujishima, Kazuhiro Imai, Ryuta Nakamura, Hiroshi Nanjo, Yoshitaro Saito, Hajime Saito, Kaori Terata, Yusuke Sato, Satoru Motoyama, Yoichi AKAGAMI et al. · 2017 · Scientific Reports
75. Smoking status and the association between patient-level factors and survival among lung cancer patients
    Nikki M. Carroll, Andrea N. Burnett‐Hartman, Katharine A. S. Rendle, Christine M Neslund-Dudas, Robert T. Greenlee, Stacey Honda, Anil Vachani, Debra Pearson Ritzwoller · 2023 · JNCI Journal of the National Cancer Institute
76. Identifying druggable targets from active constituents of Azadirachta indica A. Juss. for non‐small cell lung cancer using network pharmacology and validation through molecular docking
    Rajat Nath, Somorita Baishya, Deepa Nath, Lutfun Nahar, Satyajit Dey Sarker, Manabendra Dutta Choudhury, Anupam Das Talukdar · 2023 · Phytochemical Analysis
77. Diverse clinical outcomes for the EGFR‑mutated and ALK‑rearranged advanced non‑squamous non‑small cell lung cancer
    Chun-Wei Lin, Kuo‐Yang Huang, Ching‐Hsiung Lin, Ming‐Hon Hou, Sheng‐Hao Lin · 2025 · Oncology Letters
78. A Semi‐Supervised Transformer Survival Prediction Model for Lung Cancer
    Jing Teng, Lan Yang, Shan Wang, Jing Yu · 2025 · Advanced Functional Materials
79. [Current Status for Anaplastic Lymphoma Kinase in Non-small Cell Lung Cancer].
    Peng Song, Li Zhang, Congcong Shang · 2018 · Europe PMC (PubMed Central)
80. Patient-led advocacy in ALK-positive lung cancer
    Colin Barton, Morhaf Al Achkar, Jennifer A. Blender, S. Farmen, R.B. Hall, Afroditi Maria Konidari, Debbi Martinez, Nancee Pronsati, Marc Rosenzweig, Carla Vass et al. · 2023 · Translational Lung Cancer Research
81. Targeted RT study: results on early toxicity of targeted therapies and radiotherapy
    Dinah Konnerth, Aurélie Gaasch, Christoph Benedikt Westphalen, Kathrin Heinrich, Maximilian Niyazi, Chukwuka Eze, Paul Rogowski, Sebastian Norbert Marschner, Annemarie Zinn, Claus Belka et al. · 2024 · Radiation Oncology
82. Immunohistochimie PD-1/PD-L1 en oncologie thoracique : où en sommes-nous ?
    Paul M Hofman, Marius Ilié, Sandra Lassalle, Élodie Long-Mira, Coraline Bence, Catherine Butori, Véronique Hofman · 2017 · Annales de Pathologie
83. Single‐center study to determine the safety and efficacy of CT‐707 in Chinese patients with advanced anaplastic lymphoma kinase‐rearranged non‐small‐cell lung cancer
    Peng Song, Xiaotong Zhang, Dongliang Yang, Hanping Wang, Xiaoyan Si, Li Zhang · 2020 · Thoracic Cancer
84. A novel recurrence-associated metabolic prognostic model for risk stratification and therapeutic response prediction in patients with stage I lung adenocarcinoma
    Chengming Liu, Sihui Wang, Sufei Zheng, Xin‐Feng Wang, Jianbin Huang, Yuanyuan Lei, Shuangshuang Mao, Xiaoli Feng, Nan Sun, Jie He · 2021 · Cancer Biology and Medicine
85. Improving Classification Accuracy of Pulmonary Nodules using Simplified Deep Neural Network
    Shital D. Bhatt, Himanshu B. Soni · 2021 · The Open Biomedical Engineering Journal
86. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis
    Shengjin Cui, Shuang Lou, Jingying Feng, Xi Tang, Xiaowei Xiao, Rong Huang, Weiquan Guo, Yiwen Zhou, Feixia Huang · 2022 · Translational Cancer Research
87. A case report of pulmonary combined small cell carcinoma with enteric adenocarcinoma
    Shouguang Wang, Ye Tan, Ling Li, Yaxuan Zhang, Chuang Liu, Pengyao Du, Fanfan Meng, Bo Li · 2022 · Translational Cancer Research
88. Can p40 (Polyclonal) Replace p63 (Clone 4A4) in the Cytologic Diagnosis of Pulmonary Non–Small Cell Carcinoma?
    Melissa Alexander, Jeanine M. Chiaffarano, Fang Zhou, Joan F Cangiarella, Melissa Yee‐Chang, Aylin Simsir · 2017 · American Journal of Clinical Pathology
89. A Novel Tool for the Risk Assessment and Personalized Chemo-/Immunotherapy Response Prediction of Adenocarcinoma and Squamous Cell Carcinoma Lung Cancer
    Hai Chen, Xianquan Xu, Tengfei Ge, Congshu Hua, Xiaodong Zhu, Qikui Wang, Zaicheng Yu, Renquan Zhang · 2021 · International Journal of General Medicine
90. Individualized Treatment for Advanced Non-Small Cell Lung Cancer: A Case Report and Literature Review
    Qianqian Sun, Weiqing Li, Taorui Liu, Huiqin Guo · 2022 · Frontiers in Oncology
91. Combined Atezolizumab and Chemotherapy for a Patient With Double Primary Cancers
    Shinichiro Okauchi, Yuika Sasatani, Gen Ohara, Katsunori Kagohashi, Hiroaki Satoh · 2019 · In Vivo
92. The diagnostic value of 68Ga-NOTA-MAL-Cys-MZHER2:342 PET/CT imaging for HER2-positive lung adenocarcinoma
    Shu Li, Ke Wang, Xue Zhu, Donghui Pan, Lingling Wang, Xu Guo, Xiaomin Gao, Qing Luo, Xun Wang · 2024 · Frontiers in Medicine
93. Comparison of Different ROS1 Immunohistochemistry Clones and Consistency with Fluorescence In Situ Hybridization Results in Non-Small Cell Lung Carcinoma
    Onur Dülger, Büğe Öz · 2023 · Balkan Medical Journal
94. Efficient Lung Cancer Molecular Diagnostics by Combining Next Generation Sequencing with Reflex Idylla Genefusion Assay Testing
    Dingani Nkosi, Giby V. George, Huijie Liu, Meghan Buldo, Moises J. Velez, Zoltán N. Oltvai · 2023 · Genes
95. Validation of the ALK-Brain Prognostic Index for patients with ALK-rearranged lung cancer and brain metastases
    Ioannis Zerdes, Caroline Kamali, Andreas Koulouris, Mei Elsayed, Johannes Schnorbach, Petros Christopoulos, Georgios Tsakonas · 2023 · ESMO Open
96. DEPDC1 is a potential therapeutic target in lung adenocarcinoma
    Liuxiang Wang, Yueguang Xue, Xinlian Wang, Yue Pan, Shilin Li, Jie Mei, Shasha Jiang, Qian Zheng, Yang Liu, Ying Liu et al. · 2024 · Nano Today
97. Non-small cell lung cancer: the new T1 categories
    Paul E. Van Schil · 2017 · F1000Research
98. Molecular alterations in a new cell line (KU-Lu-MPPt3) established from a human lung adenocarcinoma with a micropapillary pattern
    Yukiko Matsuo, Kazu Shiomi, Dai Sonoda, Masashi Mikubo, Masahito Naito, Yoshio Matsui, Tsutomu Yoshida, Yukitoshi Satoh · 2017 · Journal of Cancer Research and Clinical Oncology
99. Checkpoint inhibitors for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent: a generic protocol
    Zhen Zhu, Kexun Zhang, Ning Cai, Edward Charbek, Aaron Miller, Sibo Zhu, Chen Suo, Xingdong Chen, Huan Song · 2019 · Cochrane Database of Systematic Reviews
100. Multicenter real‐world data of patients harboring rare mutations other than EGFR or ALK in advanced or metastatic non‐small cell lung cancer
     Su Yeon Lee, Young‐Chul Kim, Kye Young Lee, Sung Yong Lee, Shin Yup Lee, Min Ki Lee, Jeong Eun Lee, Seung Hun Jang, Tae Won Jang, Chang‐Min Choi · 2021 · Thoracic Cancer